(Q51584855)

7 April 2018

title

Pharmacokinetics of vinorelbine in patients with liver metastases. (English)

1 reference

7 April 2018

1 reference

4

1 reference

7 April 2018

Silvio Monfardini

object named as

S Monfardini

9

0 references

author name string

I Robieux

1

1 reference

7 April 2018

R Sorio

2

1 reference

7 April 2018

E Borsatti

3

1 reference

7 April 2018

V Vitali

5

1 reference

7 April 2018

P Aita

6

1 reference

7 April 2018

A Freschi

7

1 reference

7 April 2018

E Galligioni

8

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 January 1996

1 reference

7 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

7 April 2018

volume

59

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

page(s)

32-40

1 reference

7 April 2018

Can severe vincristine neurotoxicity be prevented?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

A Review of the Antitumour Activity of Vinorelbine in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Vinorelbine: a horse of a different color?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Preclinical and Clinical Pharmacology of Vinca Alkaloids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Lignocaine metabolite formation as a measure of pre-transplant liver function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

MEGX test in hepatology: the long-sought ultimate quantitative liver function test?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Factors influencing the natural history of colorectal liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Natural history of patients with untreated liver metastases from colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Proposal for a clinical classification of liver metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Determination of vinorelbine (Navelbine) in tumour cells by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Pharmacodynamics in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Pharmacokinetics of vinorelbine in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Assessment of lidocaine metabolite formation as a quantitative liver function test in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

Omeprazole drug interaction studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990021-1

10.1016/S0009-9236(96)90021-1

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

8549031

1 reference

7 April 2018